BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:29 PM
 | 
Sep 20, 2012
 |  BC Extra  |  Company News

FDA approves Prolia label expansion

FDA approved an sBLA from Amgen Inc. (NASDAQ:AMGN) for Prolia denosumab to include treatment to increase bone mass in men with osteoporosis at high...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >